SKINOVATION PHARMACEUTICAL INC
10SB12G, EX-27, 2000-07-11
Previous: SKINOVATION PHARMACEUTICAL INC, 10SB12G, EX-3.3, 2000-07-11
Next: AMERICAN PHYSICIANS CAPITAL INC, S-1, 2000-07-11



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   6-MOS                   YEAR
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-END>                               JUN-30-2000             DEC-31-1999
<CASH>                                               0                       0
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                     0                       0
<PP&E>                                               0                       0
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                                       0                       0
<CURRENT-LIABILITIES>                           28,776                  28,776
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                           653                     653
<OTHER-SE>                                    (29,429)                (29,429)
<TOTAL-LIABILITY-AND-EQUITY>                         0                       0
<SALES>                                              0                       0
<TOTAL-REVENUES>                                     0                       0
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                  14,200
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                                      0                (14,200)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                (14,200)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                         0                (14,200)
<EPS-BASIC>                                          0                  (0.02)
<EPS-DILUTED>                                        0                  (0.02)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission